day 1 agenda

6th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA
at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event)
Day -1(October 01, 2025)
Tentative Program
09:00-09:30 KeynoteTalk: Novel Tau-specific aptamers: diagnostic and therapeutic potentials
Kevin K. Wang, CNMB, USA
09:30-10:00 Slot Available
10:00-10:30 KeynoteTalk: Neurogenesis And Plasticity Processes Are Similarly Affected And Damaged In Alzheimer´s Disease
José Julio Rodríguez Arellano, IKERBASQUE, Spain
Group Photo & Refreshment Break (10:30-10:50)
  Technical session-I
10:50-11:10 Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
Amanda J. Myers, University of Miami, USA
11:10-11:30 Slot Available
11:30-11:50 A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease
Alison Buchholz, The Johns Hopkins University School of Medicine, USA
11:50-12:10 Cerebral Capillopathy Nexus of Neurodegenerative disease
Charles R Joseph, Liberty University College of Osteopathic Medicine, USA
12:10-12:30 Slot Available
12:30-12:50 In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease 
Paul Chazot, Durham University, UK
Lunch Break @ Restaurant (12:50-13:40)
13:40-14:00 Hearing Loss &Tinnitus – Reducing the Risk of Cognitive Decline
Keith N. Darrow, Worcester State University, USA
14:00-14:20 ‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease
Raja Banerjee, MAKAUT, India
14:20-14:40 One-week inpatient cognitive behavioral therapy for insomnia: a retrospective study
Qifang Li, Tongji university, China
14:40-15:00 Slot Available
15:00-15:20 Dihydromyricetin as a Dual-Target Neuroprotector: Clearing Tau and Aβ for Alzheimer's Disease Intervention
Judy Qiao, Towncom International Group, USA
15:20-15:40 Slot Available
15:40:16:00 Older adults with dementia:knowledge and attitudes of physicians in health units
ANA BEATRIZ QUINTES STEINER, UNIFESP, Brazil
Refreshment Break(16:00-16:20)
16:20:16:40 Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study
Paul Chazot, Durham University, UK
16:40-17:00 Slot Available
17:00-17:20 Electromagnetic field stimulation ameliorates cognitive deficits and induces neurogenesis in Alzheimer’s disease rat model
Suman Jain, AIIMS, India
Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org
Day-1 Concludes

day 2 agenda

Day 2 Program Will be updated soon.

posters agenda

Day -2(October 02, 2025)
Poster Presentations
PP-1 In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease 
Yunxi Zhang, Durham University, UK
PP-2 FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice
Christakis Damianou, Cyprus University of Technology, Cyprus
PP-3 Slot Available
PP-4 Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study
Norah Alanazi, Durham University, UK
PP-5 Slot Available
Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org

posters agenda

Tentative Program
Day -1(October 01, 2025)
Virtual Program
09:00-09:20 CareWindow: Enhancing Communication for Seniors and Individuals with Disabilities
Zachary Bailey, Care Window, Australia
09:20-09:40 Slot Available
09:40-10:10 Keynote Talk: Sex-specific brain protection in the clinical scenario: the case of davuentide
Illana Gozes, Tel Aviv University, Israel
10:10-10:30 Metric and temporal relationships in collaborative map drawings
Bernard Guelton, Université Paris 1 Panthéon Sorbonne, France
10:30-10:50 Slot Available
10:50-11:10 P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little?
Caroline Jose,Vitalité Health Network, Canada
11:10-11:30  Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial
Dean Ornish,  Preventive Medicine Research Institute, USA
11:30-11:50 Slot Available
11:50-12:10 Successes and Challenges: Insights from the first six months of the CONNECT program
Chitrali R. Mamlekar & Melissa A. Alunni, Misericordia University, USA
12:10-12:30 Slot Available
12:30-12:50 Clinicians' Reluctance to Implement a Deeply Demented Patient's Advance Directive: A Broken Moral Compass  
Norman L. Cantor, Retired from Rutgers University, USA
12:50-13:10 Slot Available
13:10-13:30 An integrative review about electrophysiological biomarkers of cognitive impairment in Alzheimer’s disease: A developing relationship
Ezra C. Holston, University of Nevada Reno, USA
13:30-13:50 Slot Available
13:50-14:10 Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Clifford R. Jack, Mayo Clinic, USA
Day -2(October 02, 2025)
Virtual Program
09:00-09:20 A perspective on physical therapy approaches in motor function neurorehabilitation
Fengxue Qi, Beijing Sport University, China
09:20-09:40 Slot Available
09:40-10:00 Students’ core self-evaluation, psychological capital, and academic engagement: A case study of Romania and Serbia
Elena Mirela Samfira, University of Life Sciences „King Mihai I” from Timisoara, Romania
10:00-10:20 Slot Available
10:20-10:40 Passive exposure to novel stimuli drives neural adaptation that encodes stimulus statistics in songbird auditory forebrain
David S. Vicario, Rutgers University, USA
10:20-10:40 Slot Available
10:40-11:00 Understanding Systems and Cognitive Process to Lead Change with Compassion
Elizabeth Wilhelm-Alderton & Renae Swanson, University of Wisconsin - Oshkosh, USA
11:00-11:20 Slot Available
11:20-11:40 OXYGEN-OZONE THERAPY AND COGNITIVE FRAILTY: A NONPHARMACOLOGICAL APPROACH TO POTENTIALLY RESOLVE IMMUNE AND INFLAMMATORY DYSFUNCTIONS
Antonio Carlo Galoforo, University of Pavia, Italy
11:40-12:00 Slot Available
12:00-12:20 Severe COVID-19 is associated with transcriptomic signatures of aging in the human brain
Maria Mavrikaki, Harvard Medical School, USA
12:20-12:40 Slot Available
12:40-13:00 Psychosocial factors associated with the risk of developing psychosis in Mexico
Tecelli Domínguez Martínez, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico
13:00-13:20 Slot Available
13:20-13:40 How Children Learn To Understand Language Meanings
Stephen Grossberg, Boston University, USA
13:40-14:00 Slot Available
Abstract submissions are open now. To schedule your talk in the program please email to: dementiacongress@innovinc.org

Download